Home / Inspections / 1202435

FDA Inspection 1202435 — Halo Pharmaceutical Canada Inc

Halo Pharmaceutical Canada Inc — FEI 3009856628

The FDA completed an inspection of Halo Pharmaceutical Canada Inc on February 17, 2023 in Mirabel. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2023
Fiscal Year
2023
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Mirabel (Canada)

Facility

Other inspections at this facility

  • 1030363 (NAI Fri Sep 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 949035 (NAI Thu Nov 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903523 (VAI Fri Nov 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources